Stay updated on Obeticholic Acid in NASH Clinical Trial
Sign up to get notified when there's something new on the Obeticholic Acid in NASH Clinical Trial page.

Latest updates to the Obeticholic Acid in NASH Clinical Trial page
- Check6 days agoChange DetectedDeleted the topic tag 'Non-alcoholic fatty liver disease' and the related topic 'MedlinePlus Genetics' from the study page metadata.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. The previous revision tag was removed and the new revision tag added.SummaryDifference0.0%

- Check42 days agoChange DetectedMinor metadata updates: 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' were added as related topics, and the revision version updated from 3.4.0 to 3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.4 added and Revision: v3.3.3 removed from the Study Documents section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check86 days agoChange DetectedLocations section updated to include a comprehensive list of site locations by state and country, expanding the geographic reach of the trial. The HHS Vulnerability Disclosure entry and several location groupings were removed.SummaryDifference1%

Stay in the know with updates to Obeticholic Acid in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeticholic Acid in NASH Clinical Trial page.